Drug Target Review

MAY 23, 2023

The algae-derived non-digestible oligosaccharides can also influence the expression of cytokines that regulate the immune system. Pharmaceutical companies meanwhile need to reinvest in natural product research. 9 Academic scientists researching natural products often struggle with the pitfalls of drug development.

Drugs 75

Drugs Small Molecule Production Disease 75

H1 Blog

DECEMBER 11, 2024

Drug Pricing, Global Diversity Strategies, & Emerging AI Applications Each year, we compile our predictions to provide life sciences, pharmaceutical, and healthcare organizations with a comprehensive look at emerging industry trends and dynamics to help them prepare for the year ahead.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

The Pharma Data

DECEMBER 17, 2020

Hartfield previously served as CEO of Vitae Pharmaceuticals prior to its acquisition by Allergan. X4 Pharmaceuticals – Diego Cadavid was named chief medical officer of Boston-based X4 Pharmaceuticals. Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs.

Small Molecule 52

Small Molecule Clinical Development Engineering Pharmaceuticals 52

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. What is a value-added medicine? To comply with the law.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

Advarra

JULY 19, 2022

The sponsor is the pharmaceutical company conducting the trial. The standard for the audit used depends on the type of vendor and would include the applicable regulations and ICH guidelines. A: Working in a pharmaceutical company is the best way to learn this. A: This does not usually happen.

Packaging 52

Packaging FDA Trials Regulations 52

Drug Target Review

MAY 26, 2025

Daniel Galbraith, Chief Scientific Officer at Solvias , brings extensive expertise in the pharmaceutical and biotechnology sectors. In his role, he provides both strategic and technical guidance to Solvias, a global Contract Research Organisation (CRO) that offers critical analytical services to the pharmaceutical industry.

Drug Development 52

Drug Development Drugs Therapies Pharmaceuticals 52

Codon

FEBRUARY 13, 2024

Regulators traditionally want to see a single, stable, well-characterized drug before giving the green light for it to be tested in a clinical trial, not dozens of different viruses; let alone ones that are best found in unappealing places like sewage , hospital waste, or bird poop. 4 But the same barriers still exist today. .

Therapies 137

Therapies Virus DNA Clinical Trials 137

The Anticancer Fund

JUNE 7, 2022

Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib Published in Pharmaceutical Research This paper reports on an innovative way for using existing non-cancer drugs to reduce the dose and to potentially improve efficacy of approved expensive anticancer drugs.

Drugs 40

Drugs Clinical Trials Trials Treatment 40

The Pharma Data

MAY 13, 2021

Before I show you what this breakthrough pain solution is, I want to let you in on the “dirty little secret” of the pharmaceutical industry. ” Here’s The Dirty Little Secret Of The Pharmaceutical Industry. Why did the big pharmaceuticals maker under express or hide the potential for addictions with opiates.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

Drug Target Review

MARCH 13, 2025

The journey from distrust to collaboration among industry, academia and regulators will expedite integration, minimise clinical failures and enhance economic sustainability. Techbio companies have initiated this approach. FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine.

Drug Development 59

Drug Development Science Clinical Trials Drugs 59

The Pharma Data

DECEMBER 30, 2020

The reason for this is still not understood and many regulators may want it to be explained before authorizing it for broader use. It also calls for ending the tax deductions that pharmaceutical companies can take for the amount of money it spends on advertising its medications. They are: • BioMarin Pharmaceutical.

Vaccine 52

Vaccine FDA Trials Therapies 52

Drug & Device Law

APRIL 7, 2023

The case is Vanda Pharmaceuticals, Inc. 27, 2023), and the plaintiff was a pharmaceutical company that wanted to know what the FDA really thought of its drug. The company lodged a request under the Freedom of Information Act (“FOIA”), which the FDA refused. 22-cv-938, 2023 U.S. LEXIS 51853 (D.D.C. Here is what happened.

FDA 64

FDA Government Pharma Companies Regulations 64